SPHERA FUNDS MANAGEMENT LTD.

CIK 00014962014 companiesTEL AVIV, L3

SEC Profile

Transactions

Companies

Filings

CIK

0001496201

Recent Transactions

50 trades

Purchase
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04$16.00/sh+475,000→ 787,997 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04+312,997→ 312,997 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Series B Preferred Stock
2021-05-04−2,713,410→ 0 total
Sale
NeurogesX Inc
Common Stock
2011-08-10$2.00/sh−82,109→ 0 total
Sale
NeurogesX Inc
Common Stock
2011-08-09$2.15/sh−81,359→ 82,109 total
Sale
NeurogesX Inc
Common Stock
2011-06-27$2.10/sh−1,079→ 163,468 total
Sale
NeurogesX Inc
Common Stock
2011-06-24$2.10/sh−7,499→ 164,547 total
Sale
NeurogesX Inc
Common Stock
2011-06-23$2.09/sh−50,000→ 172,046 total
Sale
NeurogesX Inc
Common Stock
2011-06-16$2.95/sh−80,192→ 129,437 total
Sale
NeurogesX Inc
Common Stock
2011-06-16$2.95/sh−18,810→ 33,332 total
Sale
NeurogesX Inc
Common Stock
2011-06-16$3.20/sh−300,000→ 222,046 total
Sale
NeurogesX Inc
Common Stock
2011-06-16$2.95/sh−80,192→ 129,437 total
Sale
NeurogesX Inc
Common Stock
2011-06-16$2.95/sh−18,810→ 33,332 total
Sale
NeurogesX Inc
Common Stock
2011-06-16$3.20/sh−300,000→ 222,046 total
Sale
NeurogesX Inc
Common Stock
2011-06-03$2.22/sh−3,300→ 209,629 total
Sale
NeurogesX Inc
Common Stock
2011-06-02$2.36/sh−14,425→ 212,929 total
Sale
NeurogesX Inc
Common Stock
2011-06-02$2.36/sh−3,382→ 52,142 total
Sale
NeurogesX Inc
Common Stock
2011-06-01$2.46/sh−2,090→ 55,524 total
Sale
NeurogesX Inc
Common Stock
2011-06-01$2.46/sh−8,910→ 227,354 total
Sale
NeurogesX Inc
Common Stock
2011-03-28$4.07/sh−9,853→ 236,264 total
Sale
NeurogesX Inc
Common Stock
2011-03-28$4.07/sh−2,463→ 57,614 total
Sale
NeurogesX Inc
Common Stock
2011-03-24$4.07/sh−32,600→ 642,046 total
Sale
NeurogesX Inc
Common Stock
2011-03-24$4.02/sh−120,000→ 522,046 total
Sale
NeurogesX Inc
Common Stock
2011-03-23$4.00/sh−17,575→ 246,117 total
Sale
NeurogesX Inc
Common Stock
2011-03-23$4.00/sh−4,125→ 60,077 total
Sale
NeurogesX Inc
Common Stock
2011-03-23$4.01/sh−12,100→ 674,646 total
Sale
NeurogesX Inc
Common Stock
2011-03-01$3.53/sh−1,494→ 64,202 total
Sale
NeurogesX Inc
Common Stock
2011-03-01$3.53/sh−6,806→ 263,692 total
Sale
NeurogesX Inc
Common Stock
2011-02-28$3.87/sh−5,808→ 65,696 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2010-07-12$4.15/sh−20,000→ 571,877 total
Purchase
NeurogesX Inc
Common Stock
2010-07-01$6.39/sh+4,100→ 270,498 total
Purchase
NeurogesX Inc
Common Stock
2010-06-30$6.65/sh+10,501→ 266,398 total
Purchase
NeurogesX Inc
Common Stock
2010-06-28$7.16/sh+7,000→ 71,504 total
Purchase
NeurogesX Inc
Common Stock
2010-05-04$9.94/sh+5,217→ 64,504 total
Purchase
NeurogesX Inc
Common Stock
2010-03-31$9.44/sh+12,000→ 255,897 total
Purchase
NeurogesX Inc
Common Stock
2010-03-29$9.51/sh+8,000→ 243,897 total
Purchase
NeurogesX Inc
Common Stock
2010-02-10$7.28/sh+33,700→ 686,746 total
Purchase
NeurogesX Inc
Common Stock
2010-02-10$7.26/sh+10,000→ 235,897 total
Purchase
NeurogesX Inc
Common Stock
2010-02-09$7.20/sh+500→ 223,897 total
Purchase
NeurogesX Inc
Common Stock
2010-02-09$7.20/sh+2,000→ 225,897 total
Purchase
NeurogesX Inc
Common Stock
2010-01-29$7.06/sh+5,521→ 653,046 total
Purchase
NeurogesX Inc
Common Stock
2010-01-07$7.09/sh+2,500→ 647,525 total
Purchase
NeurogesX Inc
Common Stock
2010-01-04$7.66/sh+5,000→ 645,025 total
Purchase
NeurogesX Inc
Common Stock
2009-12-31$7.81/sh+2,400→ 640,025 total
Purchase
NeurogesX Inc
Common Stock
2009-12-30$7.60/sh+2,500→ 637,625 total
Purchase
NeurogesX Inc
Common Stock
2009-12-29$7.37/sh+3,100→ 635,125 total
Purchase
NeurogesX Inc
Common Stock
2009-12-14$7.82/sh+3,600→ 632,025 total
Purchase
NeurogesX Inc
Common Stock
2009-12-11$7.79/sh+5,600→ 628,425 total
Purchase
NeurogesX Inc
Common Stock
2009-12-10$7.76/sh+8,000→ 622,825 total
Purchase
NeurogesX Inc
Common Stock
2009-12-09$7.44/sh+10,000→ 614,825 total

Companies

Recent Filings

Address

PLATINUM HOUSE, 21 HA'ARBA'AH ST.

TEL AVIV, L3

View on SEC.gov